Detalhe da pesquisa
1.
Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency.
J Bone Miner Res
; 22(5): 762-70, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17280527
2.
Safety of exenatide once weekly for 52 weeks in Japanese patients with type 2 diabetes mellitus.
J Diabetes Investig
; 4(2): 182-9, 2013 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24843650
3.
Safety and efficacy of once-weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes over 84 weeks.
Diabetes Care
; 35(4): 683-9, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22357185
4.
Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world setting.
Curr Med Res Opin
; 27(3): 531-40, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21219119
5.
Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
Clin Ther
; 32(5): 896-908, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20685497
6.
Impact of race/ethnicity on the efficacy and safety of commonly used insulin regimens: a post hoc analysis of clinical trials in type 2 diabetes mellitus.
Endocr Pract
; 16(5): 818-28, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20439249
7.
High-dose insulin therapy: is it time for U-500 insulin?
Endocr Pract
; 15(1): 71-9, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19211405
8.
DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes.
Diabetes Care
; 32(6): 1007-13, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19336625
9.
Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy.
Diabetes Care
; 31(1): 20-5, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17934150